Effects of Transcranial Photobiomodulation in ADHD
Recruiting
N/A
Interventional Study
Attention Deficit Hyperactivity Disorder
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 44
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 140 (estimated)
- Sponsor
- Francisco Gonzalez-Lima, PhD · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The investigators have previously shown that non-invasive methods of brain stimulation such as the administration of transcranial infrared light to the prefrontal cortex (PFC) can result in improvements to cognition and emotion as well as brain oxygenation. This method is called transcranial photobiomodulation (tPBM).
The investigators hypothesize that tPBM can improve cognition and brain oxygena…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* English-speaking
* Adults of any sex
* Age range: 18-44 years
* Any ethnic/racial background
* Medical history of ADHD
* Participants may either be on a stable ADHD medication regimen (with no changes within two weeks prior to the study) or not taking medication.
Exclusion Cr…
Contacts